MedPath

The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcet

Not Applicable
Recruiting
Conditions
Patients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidism
Registration Number
JPRN-UMIN000027344
Lead Sponsor
Matsunami general hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iPTH, Ca, P, side effect, dosage of etelcalcetide
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath